Nano-technological Platforms and Manipulations for the Emerging Ocular Manifestations.- Phytonanomedicines as Topical Alternatives for the Treatment of Skin Cancer.- Nano-sized Labile and Particulate Ingredients in Topical Formulations: A Strategic Approach Against Photoageing and Photocarcinogenisis.- Application of Biocompatible Nanocarriers in Glaucoma: Challenges and Advances.- Nano-carriers for Natural Therapeutics in the Management of Neuropathic Pain.- Advances in the Delivery of Therapeutic Peptides.- Nanoformulations and Their Role in Colon Targeting.- Theranostic Nanoformulations: Merging Diagnostics and Therapeutics.- The Role of Nanoformulations in Nose-To-Brain Drug Delivery.- Cubic Lyotropic Liquid Crystalline Nanostructures: A Versatile Platform for Delivery.- Preformulation Challenges: The Concept Behind the Selection, Design, and Preparation of Nanoformulations.- Nanoethosomes for Topical Fungal Therapeutics.- Comparison of Therapeutic Efficiency of Nanoformulations of Curcumin vs. Tetrahydrocurcumin in Various Disorders.- Nanomedicinal Approaches of Phytotherapeutics to Treat Alzheimers Disease.- Nanoparticulate Approaches to Exploit the Pathophysiology of Rheumatoid and Osteoarthritis.- Emerging Nanotechnology in Chronic Respiratory Diseases.- Conventional and Non-conventional Approaches of Site-specific Targeting of Therapeutics in Some Infectious Diseases and Metabolic Disorders.- Nanoformulations in Human Health Conditions: The Paradigm Shift.- Magnetic Nanoparticles Nanoformulation for Alternative Therapy of Cancer by Super-paramagnetic Hyperthermia.- Nano-weapons Against Tuberculosis.- Drug-Excipient Interactions in Nanoformulations with Special Focus on Impurity Control per ICH guidelines.
Dr Sushama Talegaonkar is working as Associate Professor in Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University New Delhi. Her current research interests include development of wide variety of smart and functionalized nano drug delivery systems for various biomedical applications specially for targeted drug delivery in cancer and autoimmune disorders She has published more than 240 research papers in high impact factor International and National journals. She has co-authored eight books and authored 15 chapters in International reference books.. She has travelled to Canada, United Kingdom and Singapore to present her research papers. Dr Talegaonkar has been granted two Indian Patent and her 2 applications for Indian patents are under consideration.
Mahendra Rai is a Senior Professor and UGC- Basic Science Research Faculty Fellow at the Department of Biotechnology, Sant Gadge Baba Amravati University at Amravati, Maharashtra, India. He was a Visiting Scientist at the Department of Bioenergetics, University of Geneva, Switzerland and at the Department of Plant Protection of Debrecen University, Debrecen, Hungary . He visited Department of Chemical Biology, University of Campinas, Brazil under Indo-Brazil Research Programme (DST-CNPq collaboration). He was visiting Professor in Nicolaus Copernicus University, Torun, Poland. and visiting scientist in State University of Campinas, Brazil. He was also visiting professor in Ostrava, Czech Republic and in National University of Rosario, Argentina. His area of expertise includes microbial biotechnology and nanobiotechnology. His present research interest include application of nanobiotechnology in medicine with particular reference to the development of nanoantimicrobials. He has published more than 400 research papers in national and international journals. In addition, he has edited/authored more than 50 books and 6 patents.
This book is an amalgamation of knowledge, experience, and expertise in various aspects of nanotechnology, by experts who are proficient in designing novel nanoformulations that are used in the treatment of various challenging and prevalent diseases. It is an exhaustive compilation of the multi-faceted arena of nanoformulations and the healthcare system that caters to the needs of academicians, scholars, researchers, etc. The most important aspect of the book covers various types of nanoformulations and their applications in the treatment of communicable and non-communicable diseases. Each chapter focuses on a particular nanoformulation as well as a disease including the pathophysiology of the disease, the current treatment modalities of diseases, the role of nanoformulation in treatment and other future aspects and directions for further work. Coverage includes neuropathic pain, colon targeting, nose-to-brain drug delivery, cancer, arthritis and tuberculosis.